What is NeuroMetrix, Inc. (NURO) stock price today?

NeuroMetrix, Inc. (NURO) is currently trading at $4.58, up 5.05% today.

What is NURO P/E ratio?

NeuroMetrix, Inc.'s P/E ratio is -1.16. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is NURO return on equity (ROE)?

NeuroMetrix, Inc.'s return on equity (ROE) is -45.38%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is NeuroMetrix, Inc.'s market cap?

NeuroMetrix, Inc. has a market capitalization of $9.43M.

NASDAQ · Medical - Devices

NeuroMetrix, Inc. (NURO) Stock

$4.58 +5.05% NASDAQ: NURO Healthcare

Valuation

Metric	Value
Price	$4.58
Market Cap	$9.43M
P/E Ratio	-1.16
P/B Ratio	0.63
P/S Ratio	3.11
EPS (TTM)	$-3.96
52-Week High	$4.73
52-Week Low	$2.66
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-45.38%
ROA	-50.94%
ROCE	-61.36%
Gross Margin	55.38%
Operating Margin	-289.57%
Net Margin	-257.38%
Debt/Equity	0.01
Current Ratio	14.83

Annual Financials (USD)

Metric	2020	2021	2022	2023	2024
Revenue	$7.0M	$8.0M	$8.0M	$6.0M	$3.0M
Operating Profit	$-2.0M	$-2.0M	$-5.0M	$-7.0M	$-9.0M
Net Profit	$-2.0M	$-2.0M	$-4.0M	$-7.0M	$-8.0M
EPS	$-0.53	$-0.86	$-4.90	$-6.27	$-3.96
Op Margin	-28.4%	-27.7%	-57.4%	-121.2%	-289.6%

Balance Sheet (USD)

Metric	2020	2021	2022	2023	2024
Total Assets	$8.0M	$25.0M	$25.0M	$21.0M	$15.0M
Total Liabilities	$3.0M	$2.0M	$1.0M	$1.0M	$1.0M
Cash	$5.0M	$23.0M	$4.0M	$2.0M	$1.0M
Borrowings	$1.0M	$0	$0	$0	$0

Cash Flow (USD)

Metric	2020	2021	2022	2023	2024
Operating Cash Flow	$-2.0M	$-2.0M	$-5.0M	$-6.0M	$-7.0M
Investing Cash Flow	$0	$0	$-17.0M	$1.0M	$5.0M
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$2.0M	$17.0M	$-18.0M	$-3.0M	$0
Free Cash Flow	$-2.0M	$-2.0M	$-5.0M	$-6.0M	$-7.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.03
EV / EBITDA	-0.95
FCF Yield	-75.57%
Quick Ratio	13.50
Interest Coverage	0.00
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AAPLApple Inc.	$313.33	+0.29%	37.72	$4.60T	0.34%
MSFTMicrosoft Corporation	$499.99	+0.03%	22.95	$3.71T	0.94%
GOOGLAlphabet Inc.	$354.30	-0.96%	27.68	$4.29T	0.23%
AMZNAmazon.com, Inc.	$274.48	+0.82%	28.76	$2.95T	0.00%
METAMeta Platforms, Inc.	$592.10	+0.37%	21.47	$1.51T	0.35%

About NeuroMetrix, Inc.

NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.

NeuroMetrix, Inc. is headquartered in US.

NeuroMetrix, Inc. (NURO) stock trades at $4.58 with a market capitalization of $9.43M. The stock is valued at a price-to-earnings (P/E) ratio of -1.16, price-to-book of 0.63, price-to-sales of 3.11. Over the past 52 weeks the stock has ranged between $2.66 and $4.73, and currently trades 3.2% below its 52-week high.

On profitability, NeuroMetrix, Inc. generates a return on equity (ROE) of -45.38%, return on capital employed of -61.36%, an operating margin of -289.57%, a net profit margin of -257.38%.

Official website: www.neurometrix.com